Increasing numbers of critically ill patients develop fungal or yeast infections, which are associated with high mortality. Now a review compares treatments involving single-drug antifungal prophylaxis or a multi-drug regimen of selective digestive tract decontamination and suggests that both methods reduce yeast-related morbidity and mortality, but to different extents.